The NEI supports a broad range of basic and clinical research to:
- Identify the genes that contribute to the pathophysiology of all the forms of glaucoma
- Establish a consensus definition of OAG (Open Angle Glaucoma) and standardize tools to assess its various phenotypes
- Develop an end-point measure for OAG
- Investigate the cellular and molecular mechanisms involved in aqueous humor dynamics including the inflow and outflow pathways and the tissues comprising them
- Explore neuroprotection as an approach for prolonging RGC function and survival
- Identify the specific antigenic targets of the aberrant immune response in uveitis and scleritis and determine the role of antigens derived from apoptotic cells in disease
- Identify genes, transcription factors, and signaling molecules involved in optic nerve degeneration/regeneration
- Develop experimental approaches comparing models that differ in their optic nerve regenerative capacity, such as fish versus mammal
Program Directors
Bioengineering and Technology
Tony Gover, Ph.D.
tony.gover@nih.gov
301-529-7370
Development
Steven Henle, Ph.D.
Steve.Henle@nih.gov
301-594-5669
Regeneration
Ashley Fortress, Ph.D.
ashley.fortress@nih.gov
301-275-9944
Glaucoma
Hongman Song M.D., Ph.D
hongman.song@nih.gov
301-451-9768